COVID-19 Leading to Accelerated Rapidly Progressive Interstitial Lung Disease in Anti-MDA5 Dermatomyositis

被引：0
|
作者：
Dandu, S. [1 ]
Farhat, F. [1 ]
Akhlaq, H. [1 ]
Udongwo, N. [1 ]
Nannepaga, S. [1 ]
Nadhim, A. [2 ]
Abu Homoud, A. [3 ]
机构：
[1] Jersey Shore Univ, Med Ctr, Internal Med, Neptune, NJ USA
[2] JSUMC, Neptune, NJ USA
[3] Jersey Shore Univ, Med Ctr, Pulm & Crit Care, Neptune, NJ USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1445
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis
    So, Ho
    Wong, Victor Tak Lung
    Lao, Virginia Weng Nga
    Pang, Hin Ting
    Yip, Ronald Man Lung
    CLINICAL RHEUMATOLOGY, 2018, 37 (07) : 1983 - 1989
  • [32] Efficacy of plasma exchange in patients with anti-MDA5 rapidly progressive interstitial lung disease
    Bay, Pierre
    de Chambrun, Marc Pineton
    Rothstein, Vincent
    Mahevas, Matthieu
    De Prost, Nicolas
    Roux, Antoine
    Zuber, Benjamin
    Biet, Dominique Israel
    Hervier, Baptiste
    Tazi, Abdellatif
    Mouthon, Luc
    Mekinian, Arsene
    Deligny, Christophe
    Borie, Raphael
    Meurice, Jean Claude
    Meyer, Alain
    Priou, Pascaline
    Savale, Laurent
    Martin, Luc De Saint
    Gallay, Laure
    Cottin, Vincent
    Blanchard, Elodie
    Brillet, Pierre-Yves
    Khafagy, Philippe
    Benveniste, Olivier
    Nunes, Hilario
    Allenbach
    Uzunhan, Yurdaguel
    JOURNAL OF AUTOIMMUNITY, 2022, 133
  • [33] A RAPIDLY PROGRESSIVE AND RARE ILLNESS: AUTOANTIBODIES AGAINST MELANOMA DIFFERENTIATION-ASSOCIATED PROTEIN 5 (ANTI-MDA5): AMYOPATHIC DERMATOMYOSITIS WITH PROGRESSIVE INTERSTITIAL LUNG DISEASE THAT DEVELOPED AFTER COVID-19 VACCINE
    Carrasco, Leonel
    Arthur, Ashlie
    Rueda, Juan Gaitan
    Case, Chad
    CHEST, 2021, 160 (04) : 680A - 681A
  • [34] Case of anti-MDA-5 positive dermatomyositis with rapidly progressive interstitial lung disease
    Fenando, Ardy
    Firn, Kim
    Louissa, Stefanie
    Hussain, Ammarah
    BMJ CASE REPORTS, 2020, 13 (04)
  • [35] Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody
    Huyan Wang
    Xin Chen
    Yan Du
    Lihua Wang
    Qiyuan Wang
    Huaxiang Wu
    Lei Liu
    Jing Xue
    Arthritis Research & Therapy, 25
  • [36] Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody
    Wang, Huyan
    Chen, Xin
    Du, Yan
    Wang, Lihua
    Wang, Qiyuan
    Wu, Huaxiang
    Liu, Lei
    Xue, Jing
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [37] Rapidly progressive interstitial lung disease associated with dermatomyositis-Longitudinal course of anti-MDA5 antibody titer in two cases
    Awaji, Kentaro
    Asano, Yoshihide
    Fukui, Yuki
    Oka, Tomonori
    Toyama, Tetsuo
    Sato, Shinichi
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2021, 4 (04) : 78 - 81
  • [38] A Fatal Case of Anti-MDA5 Antibody Positive Clinically Amyopathic Dermatomyositis (CADM) Associated with Rapidly Progressive Interstitial Lung Disease
    Mohammed, A.
    Torres, C.
    AlNabulsi, M.
    Smith, S. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [39] Janus kinase inhibition in induction treatment of anti-MDA5 juvenile dermatomyositis-associated rapidly progressive interstitial lung disease
    Chan Ng, Poh Lin Pauline
    Mopur, Archana
    Goh, Daniel Yam Thiam
    Ramamurthy, Mahesh Babu
    Lim, Michael Teik Chung
    Lim, Lee Kean
    Ooi, Pei Ling
    Ang, Elizabeth Youning
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2022, 25 (02) : 228 - 231
  • [40] Successful rescue treatment of refractory anti-MDA5 autoantibody positive dermatomyositis with rapidly progressive interstitial lung disease using daratumumab
    Chua, C. -G.
    Chai, G. -T.
    Lim, X. -R.
    Manghani, M.
    Leung, B. P. L.
    Koh, L-W
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (02) : 460 - 461
12345